A Randomized, Phase II Study with Biomarker Analysis of Panobinostat with or without Rituximab in Relapsed Diffuse Large B Cell Lymphoma

被引：0
|
作者：
Assouline, Sarit [1 ]
Crump, Michael [2 ]
Nielsen, Torsten Holm [1 ]
Alcaide, Miguel [3 ]
Macdonald, David [4 ]
Tosikyan, Axel [5 ]
Haliotis, Tina [1 ]
Greenwood, Celia [1 ]
Oros, Kathleen Klein [1 ]
Morin, Ryan [3 ]
Johnson, Nathalie [6 ]
Mann, Koren Kathleen [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada
[4] QEII Hlth Sci Ctr, Halifax, NS, Canada
[5] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[6] McGill Univ, Jewish Gen Hosp, Hematol, Montreal, PQ H3T 1E2, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
    Assouline, Sarit E.
    Nielsen, Torsten Holm
    Yu, Stephen
    Alcaide, Miguel
    Chong, Lauren
    MacDonald, David
    Tosikyan, Axel
    Kukreti, Vishal
    Kezouh, Abbas
    Petrogiannis-Haliotis, Tina
    Albuquerque, Marco
    Fornika, Daniel
    Alamouti, Sepideh
    Froment, Remi
    Greenwood, Celia M. T.
    Oros, Kathleen Klein
    Camglioglu, Errol
    Sharma, Ayushi
    Christodoulopoulos, Rosa
    Rousseau, Caroline
    Johnson, Nathalie
    Crump, Michael
    Morin, Ryan D.
    Mann, Koren K.
    BLOOD, 2016, 128 (02) : 185 - 194
  • [2] Panobinostat in Combination with Rituximab in Heavily Pretreated Diffuse Large B-Cell Lymphoma: Results of a Phase II Study
    Barnes, Jeffrey A.
    Redd, Robert Allyn
    Jacobsen, Eric D.
    Fisher, David C.
    Freedman, Arnold S.
    Hochberg, Ephraim P.
    Takvorian, Tak
    Neuberg, Donna
    Abramson, Jeremy S.
    BLOOD, 2014, 124 (21)
  • [3] Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study
    Barnes, Jeffrey A.
    Redd, Robert
    Fisher, David C.
    Hochberg, Ephraim P.
    Takvorian, Tak
    Neuberg, Donna
    Jacobsen, Eric
    Abramson, Jeremy S.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 633 - 637
  • [4] Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Islam, Prioty
    Rizzieri, David
    Lin, Chenyu
    de Castro, Carlos
    Diehl, Louis
    Li, Zhiguo
    Moore, Joseph
    Morris, Tod
    Beaven, Anne
    CANCER INVESTIGATION, 2021, 39 (10) : 871 - 879
  • [5] Radioimmunotherapy with 131I-rituximab for relapsed diffuse large B cell lymphoma:: A phase II study preliminary report
    Leahy, M. F.
    McQuillan, A. D.
    Turner, J. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 219 - 219
  • [6] Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Ohmachi, Ken
    Niitsu, Nozomi
    Uchida, Toshiki
    Kim, Seok Jin
    Ando, Kiyoshi
    Takahashi, Naoki
    Takahashi, Naoto
    Uike, Naokuni
    Eom, Hyeon Seok
    Chae, Yee Soo
    Terauchi, Takashi
    Tateishi, Ukihide
    Tatsumi, Mitsuaki
    Kim, Won Seog
    Tobinai, Kensei
    Suh, Cheolwon
    Ogura, Michinori
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) : 2103 - +
  • [7] A MULTICENTER PHASE II STUDY OF BENDAMUSTINE WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Kim, W. S.
    Ando, K.
    Niitsu, N.
    Ogura, M.
    Takahashi, N.
    Uike, N.
    Eom, H. Seok
    Chae, Y. S.
    Tobinai, K.
    Terauchi, T.
    Tateishi, U.
    Tatsumi, M.
    Suh, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 94 - 94
  • [8] Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study
    Sehn, Laurie H.
    Matasar, Matthew J.
    Flowers, Christopher R.
    Kamdar, Manali
    McMillan, Andrew K.
    Hertzberg, Mark
    Assouline, Sarit
    Kim, Tae Min
    Kim, Won Seog
    Ozcan, Muhit
    Croft, Brandon
    Hirata, Jamie
    Cheng, Ji
    Ku, Grace
    Herrera, Alex F.
    BLOOD, 2019, 134
  • [9] Inhibition Of Histone Deacetylases With Panobinostat As a Treatment For Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: A Phase II Study By The Fondazione Italiana Linfomi
    Zaja, Francesco
    Salvi, Flavia
    Franceschetti, Silvia
    Gaidano, Gianluca
    Ladetto, Marco
    Zanni, Manuela
    Pica, Gian Matteo
    Carella, Angelo Michele
    Chiappella, Annalisa
    Volpetti, Stefano
    Zinzani, Pier Luigi
    D'Arco, Alfonso Maria
    Evangelista, Andrea
    Tucci, Alessandra
    Piccaluga, Pier Paolo
    Pileri, Stefano A.
    Fanin, Renato
    Levis, Alessandro
    BLOOD, 2013, 122 (21)
  • [10] Pembrolizumab with Rituximab in Relapsed/Refractory Follicular Lymphoma and Diffuse Large B Cell Lymphoma
    Ho, Carrie I.
    Gopal, Ajay K.
    Ujjani, Chaitra S.
    Lynch, Ryan C.
    Poh, Christina
    Voutsinas, Jenna M.
    Wu, Qian
    Vandermeer, Jacquelin
    Fromm, Jonathan R.
    Smith, Stephen D.
    BLOOD, 2023, 142
12345